A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps

NCT06639295 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Sinusitis
Nasal Polyps

Interventions

DRUG: 611
DRUG: Placebo

Sponsor

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.